GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

GSK839   Click here for help

GtoPdb Ligand ID: 13955

Compound class: Synthetic organic
Comment: GSK839 is a selective inhibitor of Mycobacterium tuberculosis tryptophan synthase (TrpAB) that is in preclinical evaluation for the treatment of tuberculosis. It is one of the compounds claimed by GlaxoSmithKline in patent WO2019034729A1 [1].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 2
Rotatable bonds 7
Topological polar surface area 127.46
Molecular weight 378.38
XLogP -1.26
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1=CC(=CC=C1C2=NN(CC3=CC=C(C=N3)F)N=N2)S(=O)(=O)NCCO
Isomeric SMILES C1=CC(=CC=C1C2=NN(N=N2)CC3=NC=C(C=C3)F)S(=O)(=O)NCCO
InChI InChI=1S/C15H15FN6O3S/c16-12-3-4-13(17-9-12)10-22-20-15(19-21-22)11-1-5-14(6-2-11)26(24,25)18-7-8-23/h1-6,9,18,23H,7-8,10H2
InChI Key ZADGDPAVPJLDBU-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Bioactivity Comments
The MIC for in vitro antimycobacterial activity against M. tuberculosis H37Rv is 0.07 μg/ml [1-2].